Hiring activity in India grew 21% YoY in November: Naukri JobSpeak

Among the sectors that witnessed growth include retail, hospitality and education. Hiring trends are ‘positive’ across all major cities and experience levels, the index found

Jocelyn Fernandes

December 03, 2021 / 11:01 IST

[Representative image]

Hiring activity in India rose 26 percent year-on-year (YoY) in November 2021 on the back of increased retail demand, festive hype and re-opening of educational institutions, as per the Naukri JobSpeak index. Trend for November ‘21 was 2,173 compared to 1,727 in November ‘20.

Among the sectors that witnessed growth include retail, hospitality and education. In fact, the retail sector picked up 47 percent for the period, showing signs of recovery amid the festive season.

Hospitality and travel also picked up more than 58 percent, while the education sector jumped over 54 percent YoY.

“Being two of the worst impacted sectors of the pandemic, the hospitality/travel and retail industry have stood out in their recovery,” said Pawan Goyal, Chief Business Officer, Naukri.com.

Hiring activity has also grown in job creation sectors such as banking and financial services, which saw over 30 percent jump, and IT and software which saw more than 50 percent growth, compared to November last year.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show